Literature DB >> 16985668

Best of the 2002 AUA Annual Meeting: Highlights of the 2002 Annual Meeting of the American Urological Association May 25-30, 2002, Orlando, FL.

.   

Abstract

Year:  2002        PMID： 16985668      PMCID： PMC1475989     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  14 in total

Review 1.  Nephron sparing surgery for renal tumors: indications, techniques and outcomes.

Authors:  R G Uzzo; A C Novick
Journal:  J Urol       Date:  2001-07       Impact factor: 7.450

2.  Combination medical therapy for symptomatic benign prostatic hyperplasia.

Authors:  Stephen J. Savage; Ann M. Spungen; Giuseppe Galea; Josephine Britanico; Jonathan M. Vapnek
Journal:  Can J Urol       Date:  1998-08       Impact factor: 1.344

3.  Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system.

Authors:  A Belldegrun; K H Tsui; J B deKernion; R B Smith
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

4.  Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging.

Authors:  K S Hafez; A F Fergany; A C Novick
Journal:  J Urol       Date:  1999-12       Impact factor: 7.450

5.  Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detection.

Authors:  K S Ross; H B Carter; J D Pearson; H A Guess
Journal:  JAMA       Date:  2000-09-20       Impact factor: 56.272

6.  A critical analysis of the interpretation of biochemical failure in surgically treated patients using the American Society for Therapeutic Radiation and Oncology criteria.

Authors:  Matthew B Gretzer; Bruce J Trock; Misop Han; Patrick C Walsh
Journal:  J Urol       Date:  2002-10       Impact factor: 7.450

7.  The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.

Authors:  H Lepor; W O Williford; M J Barry; M K Brawer; C M Dixon; G Gormley; C Haakenson; M Machi; P Narayan; R J Padley
Journal:  N Engl J Med       Date:  1996-08-22       Impact factor: 91.245

8.  Variation in prostate specific antigen results from 2 different assay platforms: clinical impact on 2304 patients undergoing prostate cancer screening.

Authors:  Richard E Link; Shahrokh F Shariat; Cuong V Nguyen; Anita Farr; Armin D Weinberg; Ronald A Morton; Barbara Richardson; David Bernard; Kevin M Slawin
Journal:  J Urol       Date:  2004-06       Impact factor: 7.450

9.  Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?

Authors:  M J Barry; W O Williford; Y Chang; M Machi; K M Jones; E Walker-Corkery; H Lepor
Journal:  J Urol       Date:  1995-11       Impact factor: 7.450

10.  Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.

Authors:  S E Lerner; C A Hawkins; M L Blute; A Grabner; P C Wollan; J T Eickholt; H Zincke
Journal:  J Urol       Date:  1996-06       Impact factor: 7.450
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.